Ultragenyx Reports First Quarter 2016 Financial Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Ultragenyx Pharma (RARE) Misses Q1 EPS by 6c
May 9, 2016 5:22 PM EDTUltragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($1.35), $0.06 worse than the analyst estimate of ($1.29).
For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.
... More